Company Quick10K Filing
Lincoln National Life Insurance
10-Q 2020-09-30 Filed 2020-11-09
10-Q 2020-06-30 Filed 2020-08-10
10-Q 2020-03-31 Filed 2020-05-12
10-K 2019-12-31 Filed 2020-03-13
10-Q 2019-09-30 Filed 2019-11-04
10-Q 2019-06-30 Filed 2019-08-05
10-Q 2019-03-31 Filed 2019-05-06
10-K 2018-12-31 Filed 2019-03-13
10-Q 2018-09-30 Filed 2018-11-06
10-Q 2018-06-30 Filed 2018-08-07
10-Q 2018-03-31 Filed 2018-05-09
10-K 2017-12-31 Filed 2018-03-13
8-K 2018-01-19

Lincoln National Life Insurance Financials

C865 Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
11 Good Energy (ELVN)
1347 Capital Corp (TFSC)
1Life Healthcare (ONEM)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
1st United Bancorp (FUBC)
2-Track Global (TTG)
20 20 Global (TWGL)
111 (YI) 0% 1,546 323 0 0 0 0 -854
1 800 Flowers Com (FLWS) 944 42% 13.3 6% 665 336 1,266 534 37 75 1,001
10x Genomics (TXG) 4,805 75% -490.3 -2% 573 151 61 46 -10 -9 4,357
12 Retech (RETC) 0 32% -0.1 -1,385% 1 20 1 0 -15 -15 1
1347 Property Insurance Holdings (PIH) 34 0% 0.4 -5% 164 108 18 0 -8 -8 -3
21st Century Oncology Holdings (RTSX)
180 Degree Capital (TURN)
1847 Holdings (EFSH) 25% -2.4 -15% 19 23 27 7 -3 -1 3
1895 Bancorp of Wisconsin (BCOW) 46,153 12,508.1 -0% 441 383 0 0 -0 4 46,142
1st Constitution Bancorp (FCCY) 165 0% 4.4 1% 1,343 1,204 0 0 14 33 144
024 Pharma (EEIG)

Balance Sheet ($MM)2017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash9471,2391,4181,2071,8481,3202,7312,238
Accounts Receivable
Inventory
PP&E
Assets281,872279,134299,785304,955299,145314,927323,196326,285
Accounts Payable
Long-Term Debt2,3742,401
Liabilities263,427261,897282,611288,004282,826296,677303,052304,509
Stockholders' Equity18,44517,23717,17416,95116,31918,25020,14421,776
Income Statement ($MM)2017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue3,4133,4043,8524,0394,0633,7643,9284,227
Cost of Revenue
Gross Profit
R&D
SG&A
Tax767542-1520-98
Net Income963407420378368133222-201
Cash Flow ($MM)2017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating370443331-1,637-1,677-378
Cash Investing-677-1,766-1,935-1,0431,161-1,843
Cash Financing5991,5021,3932,1521,9271,728